Details

MIPS - Quality Measures - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Quality Measures

Category QUALITY
Description Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge
eMeasure ID CMS135v5
First Performance Year 2017
Last Performance Year
Metric Type singlePerformanceRate
National Quality Strategy Domain ECC
Measure Type process
eMeasure UUID 40280381-52fc-3a32-0153-62239c5d1ef6
NQF eMeasure ID 2907
NQF ID 0081
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward Physician Consortium for Performance Improvement
Submission Methods electronicHealthRecord,registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_005_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec

Back to List